SUSAN ALIFF: Open Payments
NPI 1013348556 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,609 in 74 payments from 29 companies in 2025. Trend: 2023 $56 · 2024 $222 · 2025 $1,609
Food & beverage: $1,298Education: $311
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $214 |
| Gilead Sciences, Inc. | 5 | $156 |
| GlaxoSmithKline, LLC. | 4 | $119 |
| Incyte Corporation | 5 | $107 |
| SEAGEN INC. | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Daiichi Sankyo Inc. | 5 | $94 |
| ABBVIE INC. | 5 | $89 |
| PFIZER INC. | 5 | $77 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
Products named: Trodelvy, ZEJULA, DARZALEX, IBRANCE, RYBREVANT, MONJUVI, REBLOZYL, Enhertu.
Industry payments across KY — which companies pay providers there.
